Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC)

Corinne Faivre-finn, David R. Spigel, Suresh Senan, Corey Langer, Bradford A. Perez, Mustafa Özgüroğlu, Davey Daniel, Augusto Villegas, David Vicente, Rina Hui, Shuji Murakami, Luis Paz-ares, Helen Broadhurst, Catherine Wadsworth, Phillip A. Dennis, Scott J. Antonia

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Article › peer-review

1 results
- Title(descending)

Our research as part of the international PACIFIC trial, led to the approval of a new treatment (Durvalumab) which improves progression free and overall survival in Stage III Non-small cell lung cancer (NSCLC)
Corinne Faivre-Finn (Participant)
Impact: Health and wellbeing